These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 14512871

  • 21. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
    Gong ZJ, De Meyer S, van Pelt J, Hertogs K, Depla E, Soumillion A, Fevery J, Yap SH.
    Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
    [Abstract] [Full Text] [Related]

  • 22. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs.
    Xuan B, Qian Z, Hong J, Huang W.
    Virus Res; 2006 Jun; 118(1-2):150-5. PubMed ID: 16423421
    [Abstract] [Full Text] [Related]

  • 23. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
    Yang J, Bo XC, Ding XR, Dai JM, Zhang ML, Wang XH, Wang SQ.
    J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
    [Abstract] [Full Text] [Related]

  • 24. [Inhibition of hepatitis B virus replication and expression by RNA interference in vivo].
    Ying RS, Fan XG, Zhu C, Li N, Zhang BX.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):15-8. PubMed ID: 16420758
    [Abstract] [Full Text] [Related]

  • 25. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y, Huang AL, Tang N, Zhang BQ, Lu NF.
    Chin Med J (Engl); 2005 Aug 20; 118(16):1351-6. PubMed ID: 16157029
    [Abstract] [Full Text] [Related]

  • 26. Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.
    Chen Z, Xu ZF, Ye JJ, Yao HP, Zheng S, Ding JY.
    J Zhejiang Univ Sci B; 2005 Apr 20; 6(4):236-41. PubMed ID: 15754419
    [Abstract] [Full Text] [Related]

  • 27. Knockdown of damage-specific DNA binding protein 1 (DDB1) enhances the HBx-siRNA-mediated inhibition of HBV replication.
    Tang KF, Xie J, Chen M, Liu Q, Zhou XY, Zeng W, Huang AL, Zuo GQ, Wang Y, Xiang R, Ren H.
    Biologicals; 2008 May 20; 36(3):177-83. PubMed ID: 18289873
    [Abstract] [Full Text] [Related]

  • 28. RNA interference against hepatitis B virus with endoribonuclease-prepared siRNA despite of the target sequence variations.
    Tan C, Xuan B, Hong J, Dai Z, Hao R, Li Z, Huang W.
    Virus Res; 2007 Jun 20; 126(1-2):172-8. PubMed ID: 17399837
    [Abstract] [Full Text] [Related]

  • 29. Downregulation of HBx mRNA in HepG2.2.15 cells by small interfering RNA.
    Jiao J, Cao H, Chen XW, Zhou MJ, Liu ZH, Ding ZH.
    Eur J Gastroenterol Hepatol; 2007 Dec 20; 19(12):1114-8. PubMed ID: 17998838
    [Abstract] [Full Text] [Related]

  • 30. Optimal design and validation of antiviral siRNA for targeting hepatitis B virus.
    Fu J, Tang ZM, Gao X, Zhao F, Zhong H, Wen MR, Sun X, Song HF, Qian XH.
    Acta Pharmacol Sin; 2008 Dec 20; 29(12):1522-8. PubMed ID: 19026173
    [Abstract] [Full Text] [Related]

  • 31. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ, Yoo HS, Kim JC, Park CS, Choi MS, Kim M, Choi H, Min JS, Kim YS, Yoon SW, Ahn JK.
    J Ethnopharmacol; 2009 Jul 15; 124(2):189-96. PubMed ID: 19409970
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of hepatitis B virus expression and replication by RNA interference.
    Shlomai A, Shaul Y.
    Hepatology; 2003 Apr 15; 37(4):764-70. PubMed ID: 12668968
    [Abstract] [Full Text] [Related]

  • 33. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H.
    Antiviral Res; 2010 Nov 15; 88(2):169-75. PubMed ID: 20728471
    [Abstract] [Full Text] [Related]

  • 34. [Potent and specific inhibition of hepatitis B virus antigen expression by RNA interference].
    Tang N, Huang AL, Zhang BQ, Yan G, He TC.
    Zhonghua Yi Xue Za Zhi; 2003 Aug 10; 83(15):1309-12. PubMed ID: 12930684
    [Abstract] [Full Text] [Related]

  • 35. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE, Lucifora J, Durantel D, Hantz O, Chemin I, Zoulim F, Trepo C.
    Antivir Ther; 2009 Aug 10; 14(1):131-5. PubMed ID: 19320247
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA.
    Ren XR, Zhou LJ, Luo GB, Lin B, Xu A.
    J Viral Hepat; 2005 May 10; 12(3):236-42. PubMed ID: 15850463
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Therapeutic inhibition of hepatitis B virus surface antigen expression by RNA interference.
    Cheng TL, Chang WW, Su IJ, Lai MD, Huang W, Lei HY, Chang WT.
    Biochem Biophys Res Commun; 2005 Oct 28; 336(3):820-30. PubMed ID: 16153600
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.